Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan vs placebo in acute heart failure due to acute coronary syndrome
2008-001637-10Phase 4Terminated
- Sponsor
- HUTCHMED
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Acute Heart Failure (AHF), myocardial infarction (MI) and acute coronary syndrome (ACS) comparing Levosimendan plus standard therapy with Placebo plus standard therapy (2 arms). Primary endpoint: Primary: PCWP decrease AUC over 48 hours. Started Jun 2008; status: terminated.
02
Drugs
levosimendan
03
Conditions
Acute Heart Failure (AHF)myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2008-001637-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001637-10.